Cyclodextrin in Pharma Market - Global Forecast 2026-2032

The cyclodextrin in pharma market is undergoing notable transformation as innovation, stricter regulations, and evolving risk management requirements reshape how leading organizations approach excipient sourcing and formulation design. Cyclodextrins are now integral to achieving improved drug performance, stability, and compliance, making strategic selection and supplier collaboration key to operational advantage.

Market Snapshot: Cyclodextrin in Pharma Growth Outlook

The Cyclodextrin in Pharma Market experienced expansion from USD 1.38 billion in 2025 to USD 1.50 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.86%. By 2032, the sector is projected to reach USD 2.20 billion, illustrating heightened demand as pharmaceutical companies integrate cyclodextrins for solubility, stability, and patient-centric formulation objectives. This upward trend underlines the role of cyclodextrins as a strategic excipient supporting innovation, compliance, and quality-driven differentiation in drug development pipelines.

Scope & Segmentation of the Cyclodextrin in Pharma Market

Cyclodextrin Types: Native cyclodextrins—alpha, beta, and gamma—provide fundamental solubilization, while substituted derivatives such as hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin address advanced solubility, stability, and specific route of administration needs.
Routes of Administration: Technologies support oral, parenteral, ophthalmic, nasal, pulmonary, and emerging non-traditional drug delivery, each with distinct dissolution, tolerability, and stability profiles influencing excipient choice.
Application Categories: Cyclodextrins enable solubility enhancement, improve bioavailability, assist in taste and odor masking, protect against molecular degradation, and contribute to tailored release profiles for a broad range of drug products.
Pharmaceutical Program Type: Utilized across novel chemical entities, complex generics, mature pharmaceutical brands, and lifecycle management strategies, cyclodextrin selection aligns with program complexity and regulatory expectations.
Regional Markets: The Americas, Europe, Middle East & Africa, and Asia-Pacific each present distinct regulatory, manufacturing, and logistics environments that influence sourcing decisions and supplier preference.

Key Takeaways for Senior Decision-Makers

Cyclodextrins have evolved into critical design components enabling the development of new therapeutics and enhanced formulations that address contemporary industry demands.
Selection of cyclodextrin type must align with both the molecular requirements of drug substances and formulation performance targets, underscoring the importance of thorough documentation and strict impurity controls.
Regional adoption of cyclodextrins varies based on regulatory harmonization, quality documentation protocols, and local expertise, impacting supplier engagement strategies.
Substituted cyclodextrins see strong uptake where advanced solubility or stability challenges prevail, especially in sensitive or specialty pharmaceutical programs.
Ensuring long-term supply resilience is now central to risk mitigation, supported by robust multi-site manufacturing, traceable feedstocks, and transparent supply chain management.
Supplier distinction increasingly relies on providing comprehensive technical and regulatory support, moving beyond basic product availability to address client-specific compliance needs.

Tariff Impact: Navigating 2025 Sourcing and Cost Volatility

In anticipation of potential U.S. tariff shifts for 2025, companies must prepare for increased pressure on excipient procurement costs. Tariff changes may impact cyclodextrins, their derivatives, and critical upstream packaging materials, even when finished pharmaceuticals remain exempt. This environment will require procurement and quality assurance teams to reassess landed costs, strengthen dual-source strategies, and conduct additional supplier audits and comparability studies. The evolving landscape may necessitate increased inventory levels for risk mitigation while maintaining regulatory and quality standards. Over the medium term, some production and packaging functions may regionalize to manage volatility, but maintaining validated analytics and quality systems will remain essential for uninterrupted supply and compliance.

Methodology & Data Sources

This analysis employs a triangulated methodology, integrating regulatory reviews, primary interviews with formulation scientists, procurement leaders, and regulatory experts, and a cross-validated review of claims. Multiple evidence streams confirm adoption patterns, risk areas, and best practices in the cyclodextrin in pharma market.

Cyclodextrin in Pharma Market: Why This Report Matters

Provides actionable guidance for selecting, sourcing, and managing excipients in response to the evolving demands of pharmaceutical formulation and compliance.
Enables targeted supplier partnerships by clarifying documentation and technical support expectations critical to regulatory and quality assurance success.
Delivers a foundation for agile tariff and sourcing strategies, supporting informed decisions across global regions and regulatory environments.

Conclusion

Cyclodextrins are now central to the advancement of pharmaceutical formulation and supply strategies. Organizations equipped to align technical, procurement, and compliance priorities will secure resilience and competitiveness in a market that continues to evolve.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Cyclodextrin in Pharma Market, by Product Type

8.1. Modified
8.1.1. Hydroxypropyl Beta
8.1.2. Methyl Beta
8.1.3. Sulfobutyl Ether Beta
8.2. Natural
8.2.1. Alpha
8.2.2. Beta
8.2.3. Gamma

9. Cyclodextrin in Pharma Market, by Route Of Administration

9.1. Nasal
9.1.1. Drops
9.1.2. Sprays
9.2. Ophthalmic
9.3. Oral
9.3.1. Liquid
9.3.1.1. Suspensions
9.3.1.2. Syrups
9.3.2. Solid
9.3.2.1. Capsules
9.3.2.2. Powders
9.3.2.3. Tablets
9.4. Parenteral
9.4.1. Intramuscular
9.4.2. Intravenous
9.5. Topical
9.5.1. Creams
9.5.2. Gels
9.5.3. Ointments

10. Cyclodextrin in Pharma Market, by Therapeutic Area

10.1. Cardiovascular
10.1.1. Antihypertensive Agents
10.1.2. Lipid Lowering Agents
10.2. Central Nervous System
10.2.1. Antidepressants
10.2.2. Neuroprotective Agents
10.3. Infectious Diseases
10.3.1. Antibiotic Agents
10.3.2. Antiviral Agents
10.4. Oncology
10.4.1. Chemotherapeutic Agents
10.4.2. Immunotherapy Agents

11. Cyclodextrin in Pharma Market, by Application

11.1. Drug Delivery System
11.1.1. Controlled Release
11.1.1.1. Extended Release
11.1.1.2. Sustained Release
11.1.2. Targeted Delivery
11.2. Solubility Enhancement
11.3. Stability Improvement
11.4. Taste Masking

12. Cyclodextrin in Pharma Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Cyclodextrin in Pharma Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Cyclodextrin in Pharma Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Cyclodextrin in Pharma Market
16. China Cyclodextrin in Pharma Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Ashland Global Holdings Inc
17.6. BASF SE
17.7. Caldic B.V.
17.8. Cargill Incorporated
17.9. Cerbios-Pharma SA
17.10. CycloChem Technologies Pvt. Ltd.
17.11. CycloLab Ltd.
17.12. Daicel Corporation
17.13. Hebei Tianxu Biotechnology Co Ltd
17.14. Hubei Guangji Pharmaceutical Co Ltd
17.15. Jiangsu Zhiyuan Biotechnology Co Ltd
17.16. Kleptose
17.17. Kuraray Co Ltd
17.18. Ligand Pharmaceuticals Incorporated
17.19. Merck KGaA
17.20. Nihon Shokuhin Kako Co Ltd
17.21. Roquette Frères
17.22. Samyang Corporation
17.23. Shandong Binzhou Zhiyuan Biotechnology Co Ltd
17.24. Shandong Tianli Pharmaceutical Co Ltd
17.25. Shandong Xinda Biotechnology Co Ltd
17.26. Shandong Yunzhou Biotechnology Co Ltd
17.27. Shijiazhuang Hongwei Biotechnology Co Ltd
17.28. Sichuan Kelong Chemical Co Ltd
17.29. Tokyo Chemical Industry Co., Ltd.
17.30. Wacker Chemie AG
17.31. Wuhan Sinobiological Technology Co Ltd
17.32. Zhejiang Huakang Pharmaceutical Co Ltd
17.33. Zibo Qianhui Biological Technology Co Ltd
17.34. Zibo Shuangfeng Chemical Co Ltd
17.35. Zibo Zhenhua Chemical Co Ltd

List of Figures

FIGURE 1. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CYCLODEXTRIN IN PHARMA MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CYCLODEXTRIN IN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY HYDROXYPROPYL BETA, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY HYDROXYPROPYL BETA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY HYDROXYPROPYL BETA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY METHYL BETA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY METHYL BETA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY METHYL BETA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SULFOBUTYL ETHER BETA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SULFOBUTYL ETHER BETA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SULFOBUTYL ETHER BETA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ALPHA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ALPHA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ALPHA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY BETA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY BETA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY BETA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SPRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SPRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SPRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SYRUPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIPID LOWERING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIPID LOWERING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIPID LOWERING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIDEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIBIOTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIBIOTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIBIOTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIVIRAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIVIRAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CHEMOTHERAPEUTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CHEMOTHERAPEUTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CHEMOTHERAPEUTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY IMMUNOTHERAPY AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY IMMUNOTHERAPY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY IMMUNOTHERAPY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSTAINED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSTAINED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TARGETED DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TARGETED DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLUBILITY ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLUBILITY ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLUBILITY ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STABILITY IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STABILITY IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STABILITY IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TASTE MASKING, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TASTE MASKING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TASTE MASKING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 238. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 241. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 242. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 244. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 245. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 246. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 247. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 248. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 249. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 250. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 251. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 252. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 253. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 254. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 256. EUROPE CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 276. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 278. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 279. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 280. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 281. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 282. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 283. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 284. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 285. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 286. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 287. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 288. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 289. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 290. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 291. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 292. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 294. AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 306. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 308. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 309. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 310. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 311. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 312. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 313. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 314. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 315. ASEAN CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 316. ASEAN CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 317. ASEAN CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2032 (USD MILLION)
TABLE 318. ASEAN CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
TABLE 319. ASEAN CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 320. ASEAN CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2032 (USD MILLION)
TABLE 321. ASEAN CYCLODEX

Companies Mentioned

The key companies profiled in this Cyclodextrin in Pharma market report include:

Ashland Global Holdings Inc
BASF SE
Caldic B.V.
Cargill Incorporated
Cerbios-Pharma SA
CycloChem Technologies Pvt. Ltd.
CycloLab Ltd.
Daicel Corporation
Hebei Tianxu Biotechnology Co Ltd
Hubei Guangji Pharmaceutical Co Ltd
Jiangsu Zhiyuan Biotechnology Co Ltd
Kleptose
Kuraray Co Ltd
Ligand Pharmaceuticals Incorporated
Merck KGaA
Nihon Shokuhin Kako Co Ltd
Roquette Frères
Samyang Corporation
Shandong Binzhou Zhiyuan Biotechnology Co Ltd
Shandong Tianli Pharmaceutical Co Ltd
Shandong Xinda Biotechnology Co Ltd
Shandong Yunzhou Biotechnology Co Ltd
Shijiazhuang Hongwei Biotechnology Co Ltd
Sichuan Kelong Chemical Co Ltd
Tokyo Chemical Industry Co., Ltd.
Wacker Chemie AG
Wuhan Sinobiological Technology Co Ltd
Zhejiang Huakang Pharmaceutical Co Ltd
Zibo Qianhui Biological Technology Co Ltd
Zibo Shuangfeng Chemical Co Ltd
Zibo Zhenhua Chemical Co Ltd

Table Information

Report Attribute	Details
No. of Pages	198
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.5 Billion
Forecasted Market Value ( USD ) by 2032	$ 2.2 Billion
Compound Annual Growth Rate	6.8%
Regions Covered	Global
No. of Companies Mentioned	32

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Market Snapshot: Cyclodextrin in Pharma Growth Outlook

Scope & Segmentation of the Cyclodextrin in Pharma Market

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating 2025 Sourcing and Cost Volatility

Methodology & Data Sources

Cyclodextrin in Pharma Market: Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cyclodextrin - Global Strategic Business Report

Hydroxypropyl Beta Cyclodextrin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

Dextrin Market - Global Strategic Business Report

Cyclodextrin (CAS 12619-70-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

a-Cyclodextrin (CAS 10016-20-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029